January 22, 2020
FSD Pharma Inc. announced that it has appointed Larry Kaiser, MD, FACS to its Board of Directors, effective immediately.
January 17, 2020
FSD Pharma announces that CEO Dr. Raza Bokhari, along with the founders, and other stakeholders, will ring the Nasdaq Stock...
January 9, 2020
FSD Pharma Inc. announced that its Class B Subordinate Voting Shares will commence trading on the Nasdaq Capital Market under...
January 6, 2020
FSD Pharma Inc. (CSE:HUGE) announced that it has been approved for listing on the NASDAQ Capital Market ("NASDAQ") under the...
January 2, 2020
FSD Pharma Inc. announced the appointments of three key executives: Donal Carroll, Chief Financial Officer.
December 16, 2019
FSD Pharma Inc. announces that Nasdaq has approved its application to have its Class B Subordinate Voting Shares listed on...
December 13, 2019
FSD Pharma Inc. announces that Raza Bokhari will present an overview of the Company at the Investor Summit conference.